Genome-wide networks that modulate the T-lineage cell fate
调节 T 谱系细胞命运的全基因组网络
基本信息
- 批准号:8608279
- 负责人:
- 金额:$ 38.22万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-05-15 至 2019-04-30
- 项目状态:已结题
- 来源:
- 关键词:AffectAntigen ReceptorsAttenuatedB-Cell DevelopmentBinding SitesCell LineageCellsChromosomesComplexDNA BindingDNA Sequence RearrangementDevelopmentE proteinEnhancersEpithelialExclusionGene ExpressionGene Expression ProfileGenesGenetic TranscriptionGenomeGenomicsGlobal ChangeGoalsHelix-Turn-Helix MotifsImmune System DiseasesInstructionLinkLocationMalignant NeoplasmsMediatingMolecularNamesNuclearPathway interactionsPlayPopulationProcessProtein FamilyProteinsRoleSeriesSignal TransductionStructureSwitch GenesT-Cell DevelopmentT-LymphocyteTCF3 genebasegenome wide association studygenome-widehelix-loop-helix protein differentiation inhibitormembernotch proteinnovelpreferenceprogenitorprogramspromoterresponsethymocytetranscription factor
项目摘要
The long-range goals of our studies are to understand the mechanisms that enforce the γδT and pre-TCR
checkpoints. We would like to describe these checkpoints in terms of global networks involving
transcriptional regulators, signaling components and survival factors. Previously, we as well as others
have demonstrated that E- and Id-proteins play critical roles in enforcing the γδ, pre-TCR and TCR
checkpoints. Most prominent among the E-proteins are the E2A gene products, E12 and E47. Two
additional members that are closely related to E2A, named E2-2 and HEB, also belong to the E-protein
family. The DNA binding activities of E-proteins are attenuated by a subset of helix-loop-helix (HLH)
proteins, named ld1-4.
E-proteins levels are high in T cell progenitors where they initiate TCRy, δ as well β locus rearrangement,
activate the expression of genes encoding for proteins involved in Notch- and pre-TCR signaling arid
antagonize proliferation. Once a γδ or pre-TCR complex is assembled, IdS levels are elevated to suppress
E2A DNA binding.
Here we propose to continue these studies. We would use functional studies, genome-wide analyses and
computational approaches to determine the mechanisms that underpin γδ versus β selection. We would
identify factors that cooperate with E-proteins to enforce the pre-TCR checkpoints. We would examine
whether gradients of E-protein activity modulate DNA binding site preferences as well as enhancer
repertoire selection beyond the pre-TCR checkpoint. We would examine how Notch- and pre-TCR
signaling act in concert to modulate binding site as well as enhancer selection. We would describe γδ T
cell development in terms of global networks of enhancer repertoires, interacting transcription factors,
signaling components and survival factors. We would examine how differences in signaling by the pre-
TCR and γδ TCR affect E2A occupancy and binding site selection. Finally, we would examine how these
networks change during developmental progression and how such changes relate to enforcement of the γδ
and pre-TCR checkpoints.
RELEVANCE (See instructions):
It has been established that an important population of cells, named γδ T cells, play critical roles in
preserving epithelial structures that function as barriers. The proposal described here is aimed to
understand the molecular mechanisms that promote their developmental progression. These studies may
permit novel avenues for the treatment of immune diseases and interference with the development of
malignancies.
我们研究的远程目标是了解强制执行γδT和PERE-TCR的机制
检查点。我们想根据涉及的全球网络来描述这些检查点
转录调节器,信号成分和生存因子。以前,我们和其他人
已经证明E-和ID蛋白在强制执行γδ,PER-TCR和TCR中起关键作用
检查点。 E2A基因产品E12和E47中最突出的E47。二
与E2A密切相关的其他成员,名为E2-2和HEB,也属于E蛋白
家庭。 E蛋白的DNA结合活性通过螺旋 - 环螺旋(HLH)的子集减弱
蛋白质,名为LD1-4。
e蛋白水平在T细胞祖细胞中很高,在它们启动TCRY,δ以及β基因座重排,
激活针对参与Notch-和TRE-TCR信号的蛋白质编码的基因表达
对抗增殖。一旦组装了γδ或PER-TCR复合物,IDS水平就会升高以抑制
E2a DNA结合。
在这里,我们建议继续这些研究。我们将使用功能研究,全基因组分析和
确定基础γδ与β选择的机制的计算方法。我们会的
确定与E蛋白合作以实施TCR检查点的因素。我们会检查
E蛋白活性的梯度是否调节DNA结合位点的偏好以及增强剂
曲目选择超出了TCR检查点。我们将研究Notch-和Pre-TCR
信号传导协同作用以调节结合位点以及选择增强子选择。我们将描述γδT
细胞开发在增强子库的全球网络方面,相互作用的转录因子,
信号传导成分和生存因子。我们将研究预先通过的信号传导差异
TCR和γδTCR会影响E2A的占用率和结合位点的选择。最后,我们将研究这些
网络在发育进展过程中发生变化以及这种变化的变化与γδ的实施有关
和TRE-TCR检查点。
相关性(请参阅说明):
已经确定,一个名为γδT细胞的重要细胞群在
保存充当障碍的上皮结构。此处描述的提案的目的是
了解促进其发育进展的分子机制。这些研究可能
允许新的途径用于治疗免疫识别并干扰
恶性肿瘤。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CORNELIS MURRE其他文献
CORNELIS MURRE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CORNELIS MURRE', 18)}}的其他基金
Molecular and physical mechanisms that underpin the αβ versus γδ T cell fate decision
支持 αβ 与 γδ T 细胞命运决定的分子和物理机制
- 批准号:
10462551 - 财政年份:2014
- 资助金额:
$ 38.22万 - 项目类别:
Molecular and physical mechanisms that underpin the αβ versus γδ T cell fate decision
支持 αβ 与 γδ T 细胞命运决定的分子和物理机制
- 批准号:
10226999 - 财政年份:2014
- 资助金额:
$ 38.22万 - 项目类别:
Molecular and physical mechanisms that underpin the αβ versus γδ T cell fate decision
支持 αβ 与 γδ T 细胞命运决定的分子和物理机制
- 批准号:
10685633 - 财政年份:2014
- 资助金额:
$ 38.22万 - 项目类别:
相似国自然基金
嵌合抗原受体巨噬细胞(CAR-M)微马达的制备及其血管蜂窝网络磁驱行为机理与控制方法研究
- 批准号:52375565
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
体内构建嵌合抗原受体Kupffer细胞(CAR-KC)并借助“细胞变装”策略实现肝癌双靶杀伤
- 批准号:82304398
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
双靶向CSPG4/CD126嵌合抗原受体修饰的复制缺失型弓形虫减毒活疫苗(CAR-Tg)抗恶性黑色素瘤的效应及机制研究
- 批准号:32370997
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
靶向c-MET以及CD133的串联双靶点嵌合抗原受体—巨噬细胞(CAR-M)对胰腺癌的杀伤及化疗协同增效作用及机制研究
- 批准号:82373230
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
脂质纳米粒体内介导嵌合抗原受体-M1型巨噬细胞协同TLR激动剂治疗实体瘤的研究
- 批准号:82304418
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Mechanistic elucidation of pathogenic CBM complex mutations associated with atopic disease
与特应性疾病相关的致病性 CBM 复合体突变的机制阐明
- 批准号:
10737122 - 财政年份:2023
- 资助金额:
$ 38.22万 - 项目类别:
Immunotherapy for Factor VIII Inhibition in Hemophilia A
血友病 A 中因子 VIII 抑制的免疫疗法
- 批准号:
10484774 - 财政年份:2022
- 资助金额:
$ 38.22万 - 项目类别:
Microglia and S1PR1 Signaling in Multiple Sclerosis Associated Neuropathic Pain
多发性硬化症相关神经病理性疼痛中的小胶质细胞和 S1PR1 信号转导
- 批准号:
10537095 - 财政年份:2022
- 资助金额:
$ 38.22万 - 项目类别:
Microglia and S1PR1 Signaling in Multiple Sclerosis Associated Neuropathic Pain
多发性硬化症相关神经病理性疼痛中的小胶质细胞和 S1PR1 信号转导
- 批准号:
10760221 - 财政年份:2022
- 资助金额:
$ 38.22万 - 项目类别:
Diversity Supplement: Novel specialized pro-resolving lipid mediators in resolution of aortic aneurysms and rupture
多样性补充:解决主动脉瘤和破裂的新型专业化脂质介质
- 批准号:
10239324 - 财政年份:2021
- 资助金额:
$ 38.22万 - 项目类别: